CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience
In: BMC Cardiovascular Disorders BMC Cardiovascular Disorders, Jg. 19 (2019), Heft 1, S. 1-7
Online
unknown
Zugriff:
Background The usefulness of the CHA2DS2-VASC risk score (CVRS) in predicting the occurrence of contrast-induced nephropathy (CIN) among patients with chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI) remains unclear. Method A total of 239 patients with CTO who underwent PCI were included in this study. They were divided into 3 groups according to the CVRS: low-risk group (1 point, n = 64), intermediate-risk group (2 points, n = 135), and high-risk group (≥3 points, n = 40). Baseline serum creatinine was determined upon admission before the procedure. The serum creatinine level was monitored for 72 h post-procedure to determine the occurrence of CIN. Results The total incidence of CIN in patients with CTO who underwent PCI was 16.3%. The average CVRS in the CIN group was significantly higher than that in the non-CIN group (3.1 ± 1.2 VS 2.1 ± 1.1, P
Titel: |
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience
|
---|---|
Autor/in / Beteiligte Person: | Wang, Yong ; Yu, Guo-ning ; Luan, Bo ; Hou, Ai-jie ; Zhao, Hong-wei ; Chen, Bao-jun ; Zhang, Xiao-jiao |
Link: | |
Zeitschrift: | BMC Cardiovascular Disorders BMC Cardiovascular Disorders, Jg. 19 (2019), Heft 1, S. 1-7 |
Veröffentlichung: | BioMed Central, 2019 |
Medientyp: | unknown |
ISSN: | 1471-2261 (print) |
Schlagwort: |
|
Sonstiges: |
|